A detailed history of Keystone Financial Services transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Keystone Financial Services holds 719 shares of BIO stock, worth $259,472. This represents 0.09% of its overall portfolio holdings.

Number of Shares
719
Holding current value
$259,472
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$313.15 - $374.28 $225,154 - $269,107
719 New
719 $236,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Keystone Financial Services Portfolio

Follow Keystone Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Services with notifications on news.